SEOUL: Archbishop Cheong Jin-suk
Bioethical Debate

 

 

 

Archbishop Meets Researcher As Bioethical Debate Continues

SEOUL (UCAN) -- The leader of the Korean Catholic Church met with the doctor who has made headlines through his work on embryonic stem cells to discuss the ethical implications of the controversial breakthrough.

Archbishop Nicholas Cheong Jin-suk of Seoul met Doctor Hwang Woo-suk at the archbishop's office in Myongdong Cathedral on June 15. Both agreed to respect human life, but they did not reach a consensus on the bioethical issues surrounding the use of embryonic stem cells. The meeting failed to narrow the gap between the views of the Catholic Church and Hwang on whether or not a cloned embryo is a human life.

Hwang took the initiative to set up a meeting, after having expressed his willingness to meet Archbishop Cheong and address the Church leader's criticism of the stem-cell research. Society in general perceives the archbishop, as the head of Seoul archdiocese, to be the visible leader of the Catholic Church in South Korea.

Father Mattias Huh Young-yup, Seoul archdiocese's communication director, and Professor Ahn Kyu-ri, Hwang's associate, also attended the closed-door meeting, which lasted 40 minutes. Afterward, Father Huh released a summary of the discussion in an official archdiocesan statement titled "Respect for Natural Order -- Conscience of Scientists."

"Archbishop Nicholas Cheong and Hwang talked about the various ways of stem-cell extraction and bioethical issues including the beginning of human life and the usage of women's eggs," Father Huh said in the statement.

"Archbishop Cheong said he is not against stem-cell research itself, but he opposes embryonic stem-cell research using cloned human embryos, that is, human life (in the form of) living beings," Father Huh said.

The term "human embryos" reflects Catholic teaching that life begins from the moment of conception and that destruction of a human embryo is the taking of human life. In criticizing Hwang's results, Church leaders also pointed out that the technique could lead to the cloning of human beings, rather than to the therapeutic use of stem cells, which are currently a topic of research in the treatment of serious diseases and conditions such as Alzheimer's disease.

Hwang countered that his stem-cell research does not involve the process of fertilization, of a sperm and egg coming together. The researcher "provided a detailed explanation, saying there is no scientific basis that his stem cells can be developed into a living being since there is no possibility of implantation," the statement said.

"Archbishop Cheong asked Hwang to respect and accept social worries and recommendations as much as possible with an open mind as a scientist, since high-end scientific research often progresses too fast for ethical rules to deal with," it added.

On June 16, Father Huh told UCA News, "Archbishop Cheong reaffirmed the Catholic Church's official stand that the cloned embryos are obviously human lives, and he proposed the alternative of research using adult stem cells, which is free from bioethical controversy."

 At the meeting, he said, the two sides agreed to respect human life but maintained different views on cloned embryos. "However, the meeting itself was still meaningful for the discussion of the bioethical issues."

 Hwang and his co-workers at Seoul National University published their research on the cloning of patient-specific stem cells in the May issue of the journal "Science." Their breakthrough research used genetic material from skin cells of 11 patients with serious diseases or spinal-cord injuries.

 By inserting the DNA into eggs donated by unpaid volunteers, the researchers successfully produced blastocysts, or early-stage embryos, from which they took stem cells genetically matched to each of the patients, destroying the embryos in the process.

 Embryonic stem cells can develop into the various specialized cells that form organs and other parts of the body. Medical research is exploring their use to renew or replace damaged or deteriorated tissue and organs. Adult stem cells are seen as less flexible and harder to work with than embryonic cells.

 Meanwhile, the Korean Catholic bishops issued a statement on June 4 opposing Hwang's research. In it the bishops asserted that the research is "anti-life because he clones and destroys an embryo, which is human life."

 The bishops pointed out that using embryonic stem cells "is not the only way" to treat such diseases. "Adult stem cells, which have been proved already to be effective clinically, are relatively safe and do not have any moral problem," they said.

KO8435.1346     June 20, 2005